menu
    • menu

    Company profile for Medicenna Therapeutics

    NEW Drugs in Dev: 6
    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-06-22

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medicenna is a clinical stage immunooncology company advancing novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines™ and first in class Empowered Cytokines™. We are developing a unique set of tunable Superkines™ that can be fused with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment and cancer stem cells without harming he...
    Medicenna is a clinical stage immunooncology company advancing novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines™ and first in class Empowered Cytokines™. We are developing a unique set of tunable Superkines™ that can be fused with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment and cancer stem cells without harming healthy cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Medicenna TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1920 Yonge St Toronto, Ontario, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medicenna.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/medicenna-therapeutics-corp.
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/medicenna1?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BIO International Convention

    Not Confirmed

    envelop Contact Supplier

    BIO International Convention

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medicenna Strengthens US Patent Estate for Superkine Platforms
    Medicenna Strengthens US Patent Estate for Superkine Platforms

    11 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/11/3310335/0/en/medicenna-strengthens-u-s-patent-estate-with-newly-issued-and-allowed-patents-across-its-il-2-il-4-and-il-13-superkine-platforms.html

    GLOBENEWSWIRE
    11 Jun 2026
    Share Share
    Medicenna Highlights MDNA11 in Melanoma at ASCO 2026
    Medicenna Highlights MDNA11 in Melanoma at ASCO 2026

    03 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/03/3305914/0/en/medicenna-s-mdna11-potential-in-earlier-line-melanoma-setting-highlighted-in-presentation-of-the-neo-cyt-trial-at-asco-2026.html

    GLOBENEWSWIRE
    03 Jun 2026
    Share Share
    Medicenna Closes CDN$4.44M Public Offering for Lead Programs
    Medicenna Closes CDN$4.44M Public Offering for Lead Programs

    28 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/28/3302952/0/en/medicenna-announces-closing-of-public-offering-of-units-raising-cdn-4-44-million-to-support-lead-programs.html

    GLOBENEWSWIRE
    28 May 2026
    Share Share
    Medicenna Files Prospectus Supplement and Investment Term Sheet
    Medicenna Files Prospectus Supplement and Investment Term Sheet

    22 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/22/3300037/0/en/medicenna-announces-the-filing-of-its-prospectus-supplement-and-investment-term-sheet.html

    GLOBENEWSWIRE
    22 May 2026
    Share Share
    Medicenna Finalizes Terms of Its Public Offering of Securities
    Medicenna Finalizes Terms of Its Public Offering of Securities

    19 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/19/3297332/0/en/medicenna-announces-the-finalization-of-the-terms-of-its-public-offering-of-securities.html

    GLOBENEWSWIRE
    19 May 2026
    Share Share
    Medicenna Launches Marketed Public Securities Offering
    Medicenna Launches Marketed Public Securities Offering

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3294403/0/en/medicenna-announces-the-launch-of-a-marketed-public-offering-of-securities.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search